Vitalzym Systemic Enzymes.

Bromelain is one of the proteases such blends are built on, so adding it raises the delivered protease activity of the same class. Note the total protease load rather than counting the two separately.

Papain cuts at different residue preferences from the serine proteases in a systemic blend, widening the range of peptide bonds cleaved. It is a standard member of these formulas.

Systemic enzyme blends are taken away from food so the protease is not consumed by dietary protein, while a digestive blend is taken with the meal. The two occupy different slots in the same day rather than competing.

Systemic protease blends carry fibrinolytic activity by design, and EPA shifts eicosanoid output toward the less aggregatory series. Their effects on normal clotting add together.

Ginkgolide B antagonises platelet-activating factor while the enzyme blend supports fibrin breakdown. Both act on the same normal clotting process.

Garlic organosulfur compounds lower platelet aggregation, adding to the fibrinolytic direction of a systemic enzyme blend. Worth flagging when both sit in one formula.

Systemic enzyme blends are enteric coated so the protease reaches the small intestine intact, and betaine hydrochloride is taken to lower gastric pH. The added acid load pulls against that delivery intent.

Serrapeptase is a bacterial metalloprotease and is one of the components systemic enzyme blends are built around. Combining proteases with different cleavage preferences broadens the range of peptide bonds hydrolysed by the mixture. Broadening substrate coverage is a property of the blend, not evidence of a clinical result.

Nattokinase is a subtilisin-family serine protease that degrades fibrin in vitro, and it appears alongside other proteases in systemic enzyme products. Stacking two fibrin-active proteases is additive by design, which matters most for anyone already taking something that affects clotting. Anyone in that position should raise it with their prescriber before combining.

Rutin is the traditional flavonoid companion in European proteolytic enzyme formulas and has been carried in those blends for decades. It is included as a co-formulant rather than as a protease. The pairing is a formulation convention with a long history and no combination trial cited here.

Pancreatin supplies protease, lipase and amylase activity of animal origin, covering macronutrient classes a protease-only blend does not touch. The two are used for different purposes: pancreatin with meals, a systemic blend away from them. Combining them mostly widens enzyme class coverage rather than raising any single activity.

Lipases hydrolyse triglyceride ester bonds, a reaction no protease performs. Adding lipase to a protease blend extends the substrate range to dietary fat. This is complementary specificity, straightforward enzymology, and only relevant when the product is taken with food.

Amylase cleaves alpha-1,4 glycosidic bonds in starch, again a reaction outside protease chemistry. It is a standard companion in multi-enzyme products for that reason. Its usefulness depends entirely on whether the product is taken with a starch-containing meal.

Quercetin is used alongside proteolytic enzymes in the same way rutin is, as a flavonoid co-formulant. Enzyme preparations have also been used to release flavonoid aglycones from glycosides in food-processing work. The combination in supplements is convention rather than a measured joint effect.

Curcumin and proteolytic enzymes are frequently combined in the same product because both are positioned around normal recovery after exertion. They act by different routes: one on transcription-factor signalling, the other on protein hydrolysis. No combination trial is cited for this pairing.

High-dose vitamin E reduces platelet aggregation, and fibrin-active proteases affect a separate arm of the same haemostatic system. The concern with stacking is additive, not synergistic in a helpful sense. Flag it with a prescriber if anticoagulant or antiplatelet medicine is already in use.

Gingerols inhibit thromboxane synthesis at higher intakes, which touches the same haemostatic system as fibrin-active proteases from a different angle. The interaction is worth naming rather than assuming it is trivial. The effect size for culinary amounts of ginger is small.

Salicin is converted to salicylic acid, which irreversibly inhibits platelet cyclooxygenase. Layering that on a fibrin-active enzyme blend gives two independent effects on haemostasis in the same regimen. This is established pharmacology and does not need a combination trial to warrant caution.

Acid-forming agents lower gastric pH, and low pH is exactly what an enteric coating is built to survive and what an uncoated protease is denatured by. Taking the two in the same moment works against the delivery strategy of an enteric-coated enzyme. Separating them by time is the practical answer.

Clays adsorb proteins onto their charged surfaces, and an enzyme is a protein. Taken together, a portion of the enzyme dose is likely bound and unavailable. Spacing doses apart is the standard handling of any adsorbent.

Activated charcoal binds a wide range of organic molecules, including proteins, without selectivity. Co-administration reduces how much active enzyme survives to be absorbed or to act. This is settled adsorbent behaviour rather than a supposition.

Serratial and several other proteases in these blends are zinc metalloproteases: a zinc ion sits in the active site and catalysis does not happen without it. The metal is built into the enzyme at manufacture rather than supplied by the diet at the time of dosing. The relationship is real biochemistry and does not imply that added zinc raises activity in the gut.